Navigation Links
Hadasit Bio-Holdings CEO Letter to Shareholders
Date:4/9/2013

JERUSALEM, April 9, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that it has released the following letter to its shareholders:

Dear Shareholders and Investors,

2012 proved to be a year of maturation and growth for Hadasit Bio-Holdings (HBL). Over the past twelve months our portfolio companies have advanced significantly both scientifically and operationally.  We've taken this momentum into the current year and already we are starting to reap the benefits of our diligence, patience and execution.  As a recent example, one of our flagship portfolio companies, Enlivex Therapeutics, just received orphan drug status for its ApoCell treatment.  The orphan drug status grants Enlivex seven years of exclusivity for treatment based on immune tolerance for GVHD.  This is just one example of the successful milestones our portfolio companies have been able to achieve and will continue to achieve over the coming months and years.

Not only will all of our portfolio companies continue to push forward and advance their science following the successes we had in the past year, but we will also advance ourselves from the holding company level.  For instance, in the midst of a very tough market our shareholders continued to display confidence in our growth potential after we saw over 99% participation in a rights offering we held earlier in 2012 that raised capital of over 5M NIS to be reinvested into the portfolio. 

The past year was highlighted by our portfolio companies attracting new strategic partners, earning successful results in various clinical trials, receiving sizable grants from various sources—including the Israeli government—an
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
2. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
3. Hadasit Bio-Holdings Interviewed by Wall Street Reporter
4. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
5. NeoStems CEO Letter to Shareholders
6. Genesis Biopharma Issues Letter To Shareholders
7. Bacterin Receives Letter From NYSE MKT LLC Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
8. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
9. Ronald L. Chez Files Amended 13D and Letter to the Board
10. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
11. Amarantus BioSciences Issues CEO Letter to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Specialty Pharmacy Times has ... admitted to BPA Worldwide as a business publication ... audience data for Specialty Pharmacy Times based on ... becoming a member of BPA Worldwide, Specialty Pharmacy ... clients with the most reliable, unequaled data,” said ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... May 21, 2015 Veolia’s environmental ... exclusive North American distribution agreement with VWR to ... , With more than 160 years of experience, ... services for laboratory and production facilities, has cultivated ... and differentiated services to enable science. Endetec’s ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... Nov. 20 CryoLife, Inc. (NYSE: CRY ),a ... it is scheduled to participate in the 19th Annual ... New York City on Tuesday,November 27, 2007. Steven ... deliver,the Company,s presentation beginning at approximately 1:30 p.m. EST. ...
... JOSEPH, Mich., Nov. 20 GeneGo, Inc., ... in systems biology, announced,today that Utrecht University ... program for drug innovation. MetaDrug is designed ... and off-target effects for,new compounds structures. Its ...
... Cepheid (Nasdaq:,CPHD) will present at the Piper Jaffray ... ET at The Pierre Hotel in New York. John ... Vice President,Finance and Chief Financial Officer, will provide a ... slides, may also be,accessed on Cepheid,s Web site at ...
Cached Biology Technology:CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York 2Utrecht University Licenses MetaDrug From GeneGo for Drug Innovation 2Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference 2
(Date:5/21/2015)... May 21, 2015 The Sync Project™ ... music for health, today announced a collaborative partnership with ... partnership will center on collaboration on original research, joint ... step in the collaboration, The Sync Project and BerkleeICE ... as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... owned subsidiary, 3D-ID LLC, a company engaged in biometric ... the biometrics technology portion of the recently awarded TIES ... Department of the Army. 3D-ID LLC has ... government, law enforcement and security agencies. ...
(Date:5/19/2015)...  Technology is rapidly advancing, outpacing enterprises, ability to ... Passwords and their management are soon to be rendered ... such as those developed by the FIDO Alliance™. With ... for BYOD, COPE, IoT, and mobile payments, the interconnected ... In response to the call for seamless, ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... afternoon and you have no appetite and don,t want to do ... researchers from the ARC Centre of Excellence for Coral Reef Studies ... some large reef fish feel the same way. Researcher Dr ... activities necessary for survival, including hunting for food and finding mates. ...
... have shown that Fructus corni has a protective ... and antiseptic properties. 5-hydroxymethylfurfural, a compound extracted from ... hippocampal neurons damaged by H2O2. Prof. Mingyan Wang ... for the first time, used cytobiological and molecular ...
... have been awarded the distinction of Fellow by the American ... to this rank because of their efforts toward advancing science ... of all 388 AAAS fellows for 2013 are announced in ... four Smithsonian honorees are: Helen James, research ...
Cached Biology News:Reef fish find it's too hot to swim 2Smithsonian scientists honored as AAAS Fellows 2
p-Bcl-2 (Thr 74)...
Trx-2 (71G4)...
... polyclonal to Endothelin B Receptor Like ... Receptor-Like Protein 2 (ETBR-LP-2) has been ... been isolated from human brain and ... Synthetic peptide (unfortunately, the amino acid ...
...
Biology Products: